Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999, Pharmacoepidemiology and Drug Safety, vol.8, issue.6, pp.439-485, 1980. ,
DOI : 10.1177/009286150003400101
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, pp.378-84, 2000. ,
Advanced methods for dose and regimen finding during drug development: summary of the EMA/EFPIA workshop on dose finding CPT Pharmacomet Syst Pharmacol, pp.418-447, 2014. ,
DOI : 10.1002/psp4.12196
URL : http://onlinelibrary.wiley.com/doi/10.1002/psp4.12196/pdf
Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials, Journal of Biopharmaceutical Statistics, vol.40, issue.6, pp.965-95, 2007. ,
DOI : 10.2307/2530666
Comparisons of analysis methods for proof-of-concept trials. CPT Pharmacomet Syst Pharmacol, p.23, 2013. ,
Combining Multiple Comparisons and Modeling Techniques in Dose-Response Studies, Biometrics, vol.99, issue.3, pp.738-786, 2005. ,
DOI : 10.1016/S0378-3758(01)00077-5
URL : http://www.meduniwien.ac.at/wbs/2006_13_Maerz_Bretz.pdf
Model-based dose finding under model uncertainty using general parametric models, Statistics in Medicine, vol.44, issue.7, pp.1646-61, 2014. ,
DOI : 10.1002/1521-4036(200201)44:1<101::AID-BIMJ101>3.0.CO;2-H
URL : http://arxiv.org/pdf/1305.0889
Model Selection: An Integral Part of Inference, Biometrics, vol.53, issue.2, pp.603-621, 1997. ,
DOI : 10.2307/2533961
Model averaging inconcentration-QT analyses, Pharmaceutical Statistics, vol.89, issue.4, pp.450-458, 2016. ,
DOI : 10.1080/01621459.1994.10476871
Model averaging for robust assessment of QT prolongation by concentration-response analysis, Statistics in Medicine, vol.98, issue.24, pp.3844-57, 2017. ,
DOI : 10.1198/016214503000000828
Comparison of Model-Based Tests and Selection Strategies to Detect Genetic Polymorphisms Influencing Pharmacokinetic Parameters, Journal of Biopharmaceutical Statistics, vol.5, issue.6, pp.1084-102, 2008. ,
DOI : 10.1111/j.1525-1438.2006.00593.x
URL : https://hal.archives-ouvertes.fr/inserm-00339183
Model selection and Akaike's Information Criterion (AIC): The general theory and its analytical extensions, Psychometrika, vol.10, issue.2, pp.345-70, 1987. ,
DOI : 10.1007/978-94-009-4828-0
Understanding information criteria for selection among capturerecapture or ring recovery models. Bird Study, pp.14-21, 1999. ,
DOI : 10.1080/00063659909477227
Model selection versus model averaging in dose finding studies, Statistics in Medicine, vol.5, issue.2B, pp.4021-4061, 2016. ,
DOI : 10.1214/10-AOAS445
URL : http://arxiv.org/pdf/1508.00281
Nonlinear mixed effects models for longitudinal data Statistics Reference Online [Internet] Available from, 2014. ,
Clinical pharmacology = disease progression + drug action, British Journal of Clinical Pharmacology, vol.2, issue.Suppl. 1, pp.18-27, 2015. ,
DOI : 10.1111/j.1365-2125.2012.04208.x
URL : http://onlinelibrary.wiley.com/doi/10.1111/bcp.12170/pdf
Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson???s Disease Patients, Pharmaceutical Research, vol.74, issue.2, pp.2109-2127, 2017. ,
DOI : 10.1111/j.1365-2125.2012.04208.x
URL : https://hal.archives-ouvertes.fr/inserm-01563224
Model selection and averaging of nonlinear mixedeffect models for robust phase III dose selection, J Pharmacokinet Pharmacodyn, pp.1-17, 2017. ,
DOI : 10.1007/s10928-017-9550-0
URL : https://link.springer.com/content/pdf/10.1007%2Fs10928-017-9550-0.pdf
A note on BIC in mixed-effects models, Electronic Journal of Statistics, vol.8, issue.1, pp.456-475, 2014. ,
DOI : 10.1214/14-EJS890
URL : https://hal.archives-ouvertes.fr/hal-00991708
Model Selection and Model Averaging. 1 edition. Cambridge, 2008. ,
Ranibizumab for Neovascular Age-Related Macular Degeneration, New England Journal of Medicine, vol.355, issue.14, pp.1419-1450, 2006. ,
DOI : 10.1056/NEJMoa054481
Meta-Analysis of Clinical Dose???Response in a Large Drug Development Portfolio, Statistics in Biopharmaceutical Research, vol.30, issue.4, pp.302-319, 2014. ,
DOI : 10.1161/01.CIR.54.6.885
Information theory and statistics. New edition edition, 1997. ,
Information theory, inference and learning algorithms. 1 edition, 2003. ,
NONMEM User's Guides, Icon Development Solutions, 1989. ,
Model Applied to Sparse Dose-Response Designs, Journal of Biopharmaceutical Statistics, vol.2, issue.5, pp.657-77, 2006. ,
DOI : 10.1016/S0378-3758(01)00077-5
Model, Journal of Biopharmaceutical Statistics, vol.35, issue.6, pp.1051-70, 2007. ,
DOI : 10.1080/10543400600860469